- Advertisement -spot_img
Thursday, December 2, 2021

White House plans significant expansion of Covid vaccine production

“The idea of ​​a two-company business plan rather than a public health plan worries us,” said Dr. Joya Mukherjee, chief medical officer of Partners In Health, a global public health nonprofit. “We think Biden has the power, especially with Moderna, because a lot of it was funded by taxpayers to demand the exchange of patents and know-how.”

Some activists, furious at what they perceived as the administration’s slow progress, turned up at the home of Biden’s chief of staff Ron Klein in September and threw a fake pile of bones on the sidewalk in protest. Another group protested outside Mr. Zinz’s home on Wednesday morning.

Responding to criticism that the Biden plan is not aimed at increasing capacity overseas, Dr. Kessler said domestic manufacturing “is important not only for US shipments, but also for global supply.”

At the same time, partnerships with major drug manufacturers do not provide any guarantees. Earlier this year, Biden announced that he had struck a deal with pharmaceutical giant Merck & Co. for the production of Johnson & Johnson vaccines, including for other countries. Officials called the partnership historic, saying it was in line with the president’s vision for a manufacturing campaign like the one led by Franklin D. Roosevelt to produce materials for World War II.

Read Also:  Jerome Powell keeps his job at the Fed, where he will be responsible for preventing inflation from spiraling out of control - without affecting the economy.

But the Merck deal fell short of expectations. Administration officials initially hoped Merck would begin manufacturing a key ingredient in the vaccine by the end of this year, but that won’t happen until April, Dr. Kessler said.

Congress poured a total of $ 16.05 billion into the American Rescue Plan this year in two separate tranches that could be used to purchase and manufacture drugs, vaccines and other tools to end the pandemic.

But in an analysis released this summer, AIDS advocacy group Prep4All found that the administration spent a total of $ 145 million – a total of $ 12 million from the American Rescue Plan – to expand vaccine production. Most went to modernizing Merck’s production lines.

World Nation News Deskhttps://www.worldnationnews.com
World Nation News is a digital news portal website. Which provides important and latest breaking news updates to our audience in an effective and efficient ways, like world’s top stories, entertainment, sports, technology and much more news.
Latest news
Related news
- Advertisement -

Leave a Reply